Blog
HER2 Therapies for Patients with mCRC
HER2 (human epidermal growth factor receptor 2) is a protein receptor found in all human cells and is responsible for controlling cell growth and repair. When the HER2 gene acquires mutations which cause it to be amplified or overexpressed in the cell, it promotes the growth and metastasis of different cancers, including colorectal cancer.
Overall survival associated with Pembrolizumab (Keytruda) vs. Chemotherapy in MSI-H/dMMR mCRC
May 2022 The KEYNOTE-177 trial is a landmark study in colorectal cancer treatment that evaluated the efficacy and safety of...
Alcohol intake and risk of alcohol-related cancer
April 2022. A new study from Australia found that heavy drinking in early adulthood may increase the risk for alcohol-related...
Associations between unprocessed red meat and processed meat with risk of recurrence and mortality in patients with stage III colon cancer
April 2022. A study published in JAMA Network Open investigated whether consumption of unprocessed red meat or processed meats such...
Can weight loss in adulthood reduce the risk of developing colorectal adenomas?
March 2022. While obesity is a known risk factor for colorectal cancer (CRC), the impact of weight change on the...
The emotional impact of a colorectal cancer diagnosis
https://youtu.be/-Oi2jBJDUNc February 2022. Join Patient Support Specialist, Chana, as she discusses the emotional impact of a colorectal cancer diagnosis on...
